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ABSTRACT
Introduction: Whole grain (WG) and fat content of the diet have been previously shown to affect
intestinal fermentation and phenotype conferred by high–amylose maize starch (HAM), a form
of fermentable dietary fiber. The current study was designed to compare rodent gut health
following consumption of whole grain and non–whole grain prebiotics on moderate fat (MF) and
high fat (HF) diets using a 2x2x2 factorial design.
Methods: MF and HF diets were prepared to contain the following diet sources: (1) control
starch with no WG or RS [CON], (2) whole grain waxy corn flour with low RS [WWG], (3)
purified HAM resistant starch (RS) [HAMRS], and (4) WG HAM flour rich in resistant starch
(WG+RS) [HMWG]. The eight diet conditions were fed to Sprague Dawley rats for six weeks
(n = 12 per group). After euthanasia, blood, cecal contents and cecal epithelial cells were
collected and gastro–intestinal (GI) tract portions and fat pad (retroperitoneal, perirenal, and
epididymal) weights recorded.
Results: The presence of purified RS2 resulted in greater fermentation as part of the RS*WG
interaction whereas no WG with high RS had the lowest pH of cecal contents. There was a main
effect of RS with the high RS groups having the lowest abdominal fat percent of body weight.
The presence of WG resulted in consistency of fermentation as groups with WG had similar
levels of short chain fatty acids with MF and HF diets as reflected by WG*FAT. No RS*FAT
effect was observed because of the WG consistency. Also, a greater butyrate production with
WG was demonstrated by RS*WG.

Results were primarily driven by two major effects,

reflected by the presence of and lack of some significant differences. Purified RS fermented
better on MF than HF diets. Diets with RS+WG show similar fermentation on both types of
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diets. These effects may be driven by RS1 vs. RS2 as high RS2 ferments better with MF diets,
but presence of RS1 may ferment better with HF diets.
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CHAPTER 1: INTRODUCTION
1.1. Significance of Research
Nutritional policies and recommendations regarding an adequate level of fiber (38g/day
and 25 g/day for men and women respectively) [1] have not been successfully met as most
Americans fail to meet even half the Adequate Intake [2]. New approaches must be employed to
maximize nutritional benefits within this reduced fiber consumption profile. Fiber itself is not a
singular substance and is understood to have complex chemical arrangements with a variety of
functions. One function is the degree to which the fiber is fermentable. Fermentable fiber has a
greater bioactive or biological effect than a non–fermentable fiber. It can act as a prebiotic to
promote gut health by elevating the growth of beneficial bacteria, which increases the production
of short–chain fatty acids [3–5].
The recommendations for dietary fat intake are within an acceptable macronutrient
distribution range (AMDR) between 20% and 35% of energy [1], and the average dietary fat
intake for Americans is approximately 33% of energy [6]. Studies examining the effects of fat
intake on changes in the microbiota have focused on low fat (18–20% of energy) or very high fat
(60–70% of energy) diets [7, 8]. The effects of high fat diets on the gut microbiota and the host
have been characterized, with a reduction in fermentation as a primary result [9].
Simultaneously, there exists a void in the literature when examining the effects of a moderate fat
diet on gut health. However, our lab group has begun to address this issue. In one study, we
examined the effects of a moderate fat (26% of energy) diet, and found that low and moderate fat
diets had similar effects on the fermentation of a non–whole grain resistant starch prebiotic fiber
for reducing body fat [10] and improving bacterial population (unpublished data). However, a
robust characterization of fermentation parameters produced from intake similar to what
Americans consume (moderate fat versus high fat) does not currently exist.
1

Recommendations for whole grains initially appeared in the Dietary Guidelines for
Americans 2005 [11], and current recommendations promote making at least half the grains
consumed whole grains. As with many recommendations, Americans do not meet the federal
dietary recommendations, and this is especially true for whole grains [12]. While no consensus
on whole grain consumption has been reached, many reports describe a correlation with whole
grain consumption and better health [13, 14].
It is important to determine how these bioactive components act individually, but as well
as also how they interact with each other within a dynamic system dedicated to maintaining
homeostasis. Characterizing how fat intake at levels similar to the typical American diet affect
gut health remains incomplete. Determining how moderate fat diets compare to low and high fat
diets needs to be examined. Similarly, simplifying whole grains to a singular substance begets
the confusion regarding fiber. Yet, other questions remain unanswered. Can other bioactive
components mitigate negative effects associated with high fat diets? Our lab is interested in
investigating if lower levels of fiber intake (in the form of fermentable fiber) than the current
recommendations promote a healthy gut phenotype when fed as part of a moderate fat diet
comparable to the average dietary fat intake for Americans. In the future, more people may be
able to benefit from these bioactive components without drastically altering their diet. Of course,
those who partake in more of these components may see more benefits, but those who do not
may still benefit even at reduced levels of intake.
1.2. Objectives
1. Use three bioactive components (resistant starch, whole grains, and fat) to improve gut
health.
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2. Determine if moderate dietary fat consumption provides greater health effects than high
dietary fat consumption.
3. Determine if a whole grain version of resistant starch is more efficacious than a non–
whole grain resistant starch.
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CHAPTER 2: LITERATURE REVIEW
2.1. Resistant Starch
Dietary fiber is defined as the “non–digestible carbohydrates and lignins that are intrinsic
and intact in plants.” The non–digestible carbohydrates can include inulin, oligosaccharides,
fructans, methylcellulose, polydextrose, resistant maltodextrose, resistant starch, and other
compounds [1]. The property of a starch depends on the arrangement of glycosidic bonds
linking the glucose monomers that make up the amylose or amylopectin molecules in the
granule. Using in vitro assays, Englyst et al. (1992) classified starches into three fractions: (1)
rapidly digestible starch, digested to glucose within 20 minutes, (2) slowly digestible starch,
digested between 20 and 120 minutes, and (3) resistant starch, any starch remaining after 120
minutes [15]. One function of dietary fiber is the degree to which it is fermentable. Resistant
starch is one such fermentable fiber. In the early days of fiber research, observational studies
noted a decreased risk for colorectal cancer and other bowel diseases after consuming a diet high
in unrefined grains and cereals, attributed primarily to dietary fiber. Cassidy et al. (1994)
reported one such benefit of consuming resistant starch finding a “strong inverse association
between starch consumption and large bowel cancer incidence” [16]. Topping et al. (2001)
agreed, but further attributed the benefits found in those studies primarily to resistant starch and
to a lesser degree, non–starch polysaccharides [17].
Resistant starch resists enzymatic digestion in the small intestine and is fermented by
bacteria in the large intestine [18]. Resistant starch can be classified into four major types.
Resistant starch 1 (RS1) is a component of whole– and partially milled grains, seeds and
legumes. RS1 is found in the starch granule, and the intact cell wall enclosing the granule
physically limits accessibility to enzymatic hydrolysis. Resistant starch 2 (RS2) is a highly
compacted starch in granules with reduced accessibility to enzymes that digest the glycosidic
4

bonds. RS2 found in raw starch can be gelatinized after heating, allowing amylases access to the
starch and thus, the starch becomes digestible. High–amylose maize (HAM) is high in RS2 due
to the high amylose content and having a higher gelatinization temperature that increases its
resistance against enzymatic hydrolysis. Resistant starch 3 is formed by retrograded (gelatinized
and crystallized) amylose and amylopectin. When heated, the starch’s crystalline structures
dissociate.

Upon cooling, the crystalline structures are restored, returning stability to the

molecule. Resistant starch 4 is a chemically modified starch. Modifications can emanate from
direct addition of functional groups or cross–linking other chemical reagents to starch using
novel bonds other than α–(1–4) and α–(1–6) glycosidic linkages [19]. Recently, another fraction
of resistant starch, resistant starch 5, has been described. Resistant starch 5 is produced from the
addition of lipid complexes (free fatty acids) to amylose. The pairing leads to a helical structure
that is resistant to enzymatic hydrolysis [20].
The fraction of starch that escapes enzymatic digestion in the small intestine, resistant
starch, is potentially capable of being fermented by the gut microbes in the large intestine.
Fermentation of resistant starch stimulates the growth and maintenance of the gut microflora
[21]. In this capacity, resistant starch is considered to be a prebiotic, because it is a non–
digestible food component that provides benefits to the host via microbial fermentation. The end
products of resistant starch fermentation are gases (CO2, H2 and CH4), heat, and short–chain fatty
acids (SCFAs), primarily acetic, propionic, and butyric acid, commonly called acetate,
propionate, and butyrate. Through these SCFAs, resistant starch has been shown to provide
many health benefits. Short–chain fatty acids contribute to gut health by improving energy
homeostasis and metabolism, preventing pathology in the lumen, reducing risk for a variety of
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colon cancers, gastrointestinal (GI) disorders, and beyond the gut, cardiovascular diseases. [17,
22–24].
The short–chain fatty acids vary in mode and site of actions. Acetate and propionate
produced in the colon can be found in the small and large intestines, and portal, hepatic and
peripheral blood [25]. The two SCFAs are utilized by peripheral tissues (muscle, acetate) or by
the liver (acetate, propionate) for metabolism [26–29]. Butyrate is especially important for gut
health, and is a major source of energy for epithelial colonocytes [25]. Furthermore, acetate and
lactate produced by bacteria in the gut can be utilized by bacteria in the Clostridium cluster IV,
Clostridium cluster XIV and other genera to produce butyrate [30, 31].

Resistant starch

fermentation provides benefits to the host mediated through the production of SCFAs.
2.2. Whole grains
Initially, a food or product containing more than 25% whole grain or bran content could
be defined as whole grain. This definition included high fiber bran cereals, and did not precisely
calculate the amount of whole grain present [32]. The newer definition, established with the
Food and Drug Administration Modernization Act (1997), set the criteria for manufacturers to
make health claims regarding whole grains. Under these criteria, a whole–grain food is one that
contains more than “51% or more whole grain ingredient(s) by weight per reference amount
customarily consumed” [33, 34].
A whole grain kernel consists of three parts: the bran, the germ, and a starchy endosperm.
For a food to be considered whole grain, the bran, germ, and endosperm must be present in
relative proportions as found naturally in the kernel [34]. Current recommendations for whole
grain consumption call for at least half the grains consumed to be whole grains [35]. Many
studies have described the benefits of whole grains. Whole grains have been associated with
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reduced risk for cardiovascular disease, type 2 diabetes [36, 37], cancers [38–40], and all–cause
mortality [41, 42].
While the benefits of whole grains are numerous, it is not immediately clear if the
benefits stem from the fiber or phytochemicals present. As previously mentioned, consumption
of dietary fiber in unrefined grains and cereals is associated with reduced risk for several types of
cancer and bowel diseases [38]. Similarly, phytochemicals have also been shown to provide
protection against developing chronic diseases and cancers [43]. Phytochemicals, chemicals
derived from plants, are a large class of compounds that represent thousands of possibly
bioactive molecules. Phytochemicals include carotenoids, organosulfur compounds, alkaloids,
phenolics and other nitrogen–containing compounds [44].
Research regarding phytochemicals focuses primarily on prevention, while fiber research
focuses on risk reduction [44, 45]. These concepts, while similar in thought, differ in execution.
Risk reduction focuses on strategies that mitigate harm to people who are potentially susceptible.
Furthermore, risk reduction focuses on reducing expected loss from a specific type of risk (e.g.
aphasia from a stroke). Prevention strategies focus on reducing the likelihood of an event
occurring.

Although fiber and phytochemical research does overlap, the research for both

fractions examines a different endpoint. Whole grain research can combine these strategies to
examine benefits to health. Some suggest that without the fiber component of whole grains, the
effect would be minimal [32]. This suggestion has not been explicitly tested, as the process of
separating the components would result in a product that is not whole grain.
Whole grains are capable of fermentation as is resistant starch.

Similarly, this

fermentation occurs in the large intestine by gut microbes and promotes the production of
SCFAs, gases and heat. Both the fiber component and the phytochemical component of whole
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grains have the capacity for fermentation, although some portions of the whole grain kernel may
be non–fermentable (e.g. cellulose).

Despite the benefits derived from consumption and

fermentation, whole grain intake has remained less than one–third of the recommendation [46].
However, more research is needed to elucidate the role of whole grains as both a standalone
component and mode of action affected by other nutrients and systems in the body.
2.3. Fat
Fat is a necessary macronutrient required for normal operation of the body. Fat is a
convenient and economical way to store energy in the body, but has functions well beyond the
notable energy storage. Fat is required for: (1) proper functioning of nerve cells [47], (2)
transport of vitamins A, D, E, and K [48–50], and (3) formation of some steroid hormones [51].
Dietary fat consists primarily of triacylglycerol molecules with one glycerol molecule with three
esterified fatty acid molecules attached. Dietary fats differ in many properties including degree
of saturation, cis–trans isomerism, variability in attached moiety, and conjugation.
Dietary fat has many effects on whole body health. There is evidence that some low fat,
high carbohydrate diets may modify lipoprotein and glucose/insulin metabolism in such a way
that risk for chronic disease increases [52]. Krauss (2001) described a low fat, high carbohydrate
diet lipoprotein profile, or atherogenic lipoprotein phenotype, that is minimally expressed in
healthy individuals, but is promoted in sedentary, overweight/obese populations. This profile is
associated with increased risk for coronary heart disease (CHD) when expressed in the general
American population [53]. Although the diet was low in fat, it was also high in simple sugars as
the carbohydrate source.

Thus, the diet was low in fiber which, may contribute to the

atherogenic lipoprotein phenotype. Diets high in fat, where fat is the major source of excess
energy, tend to be energy dense. These diets consumed in excess exacerbate energy control in
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obese or overweight persons. Mechanisms influencing energy density’s effect on total energy
intake have been explored.
One tenet confounding the role of fat in promoting chronic disease is the designation of
total energy intake in comparison to percentage of fat. Diets may be high or low in fat, but may
or may not alter total energy intake. The terms hypocaloric, isocaloric, and to a lesser extent,
hypercaloric impart a distinction that is important in understanding the impact of fat on body
weight. Roy et al. (2003) tested if adult female rats would adapt to lower and higher energy
density at the same level of fat. Rats in the study adjusted food intake to defend a body weight
previously adapted to a high or low energy density [54].
Regarding dietary fat content in fermentation studies in rodents, most focus on the
extreme positions. Studies focus on low (18–20% of energy) and very high (60–70% of energy)
dietary fat diets [7, 8], neglecting an intake representative of the average American (~33% of
energy). Perhaps this neglect comes from the desire to design mechanistic studies that aim to
tease out a specific outcome with a specific independent variable. Still, high fat diets (>40% of
energy) have been shown to attenuate the beneficial effects of fermentation [9]. It is suspected
that the impact of consuming a moderate fat diet (~30% of energy) on fermentation and body fat
will lie between the low and high fat diets.
2.4. Factor Comparisons
Studies have focused on producing resistant starch from various components, examining
whether whole grains are efficacious or not, and testing how fat affects the diet. Few studies
attempt to compare resistant starch, whole grains, or fat as factors that may affect each other.
For example, Lopez et al. (2000) showed that resistant starch improved mineral absorption from
wheat bran [55] and Behall et al. (2006) tested plasma glucose and insulin responses after the
addition of resistant starch and barley β–glucan to the diets of men [56] and women [57]. Still,
9

considering the potential combinations of the five resistant starch types and hundreds of
compounds that make up whole grains (vitamins, minerals, phytochemicals, lignans, fiber,
phenolics, phytosterols, and etc.), only a few studies have attempted to compare how these
bioactive components interact. Furthermore, of the few studies that do attempt to compare the
components, many are not mechanistic in nature. It is important to understand how these factors
work alone, yet nutrients have polyvalent effects [58]. To this degree, many studies have
examined the effects of these factors at low or extremely high doses. This includes studies using
resistant starch, whole grains, or fat. Studies that examine how bioactive components interact
with each other at physiological doses similar to a typical human (American) diet are needed. A
more complete characterization of how moderate and fat diets affect fermentation and gut health
in a rodent model is required. Similarly, more exploration is needed understand how other
nutritional components, such as whole grains, influence fermentation and health.
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CHAPTER 3: A STUDY OF THREE INDEPENDENT DIETARY FACTORS
IN SPRAGUE DAWLEY RATS: RESISTANT STARCH, WHOLE GRAIN
AND FAT (MODERATE, 30%, OR HIGH, 42%)
3.1. Introduction
Nutritional recommendations for fiber and whole grain consumption suggest amounts
that will deliver optimal nutrition to the consumers who stand to benefit from them [59]. These
policies promote increased fiber and whole grain consumption, and decreased fat intake
(Acceptable Macronutrient Distribution Range estimated for total fat is 20 – 35% of energy),
specifically saturated and trans fatty acids [1]. The health benefits of fiber and whole grains
have been increasingly studied in recent years. Epidemiological studies continue to demonstrate
inverse associations between biomarkers of fiber and whole grain consumption and obesity and
chronic disease risk [60].

These nutritional factors may act to promote health by several

mechanisms, and fermentation in the gut is an important process where these components may
be synergistic or antagonistic.
Dietary Fiber: Current policies and recommendations promote optimal levels of fiber for
U.S. adults (38g/day and 25 g/day for men and women, respectively) [1]. Fiber is understood to
have complex chemical arrangements and health benefits in addition to its original role as
bulking agent. Fibers are mainly composed of plant constituents, such as polysaccharides and
lignin, that resist hydrolysis by the digestive enzymes present in man, and some fibers are
capable of being fermented by bacteria in the large intestine [61]. Resistant starch (RS) is a
dietary fiber. Fermentation of RS stimulates the growth and maintenance of the gut microflora
[21]. The microflora produces many end products, including heat, gases, and short chain fatty
acids (SCFAs), and may stimulate gut hormone production. In this capacity, resistant starch is
unofficially considered to be a prebiotic, because it is a non–digestible food component that
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provides benefits to the host via microbial fermentation. Prebiotics are important to the health of
the gastrointestinal (GI) tract, providing the symbiotic link between host and the gut ecosystem.
This ecosystem, the microbiota, can respond to dietary intake and provide health benefits as a
“normobiosis.” In contrast, a “dysbiosis” is a landscape where potentially harmful micro–
organisms may populate the gut [62].
Dietary Fat: Dietary fat plays an important role in body health. It is a convenient and
economical way to store energy in the body, but has additional physiologically active roles. It
has been established that fat alone is not responsible for increasing adiposity, but consuming fat
in conjunction with a relatively unrestricted energy intake contributes to increased weight gain
[63]. Dietary fat has a complex role in the body and is useful for determining the roles of other
bioactive components in food to determine how gut health is affected. Diets that contain fiber–
rich carbohydrate and low levels of fat are both lower in calories and believed to be more
satiating. Lower energy from fat appears to be important in the prevention and treatment of
obesity. Still, many studies in humans tend to focus on consuming low (18–20% of energy) and
very high (60–70% of energy) dietary fat intake [56, 57], but neglect an intake representative of
the average American (~33% of energy).
In rodent models, studies have examined other levels of fat in the diet, improving the
characterization of dietary fat as it affects other bioactive components.

Charrier et al. (2013)

demonstrated high fat (HF) diets partially attenuated resistant starch fermentation in Sprague
Dawley rats [9]. Zhou et al. (2009) demonstrated moderate fat (MF) diets were effective at
reducing abdominal fat percentage (ABF %) as well as low fat (LF) diets when combined with
resistant starch in C57bl/6J mice [10]. These studies showed how dietary fat had different
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effects on rodent health, but human studies using diets containing fat at doses akin to average
intake still need more exploration for their roles in fermentation and chronic disease.
Whole Grains: Whole grains (WG) consist of three parts: the bran, the germ, and a
starchy endosperm [64].

For a food to be considered whole grain, the bran, germ, and

endosperm must be present in relative proportions found naturally in the kernel [34]. Present in
the bran, are dietary fiber and phytochemicals, chemicals derived from plants that include a large
class of compounds that represent thousands of possibly bioactive molecules. One of the dietary
fibers present in whole grains is resistant starch.

The germ and endosperm contain other

necessary macro– and micronutrients. Whole grains have been associated with reduced risk for
cardiovascular disease, type 2 diabetes [36, 37], cancers [38–40], and all–cause mortality [41,
42]. Despite the benefits derived from consumption and fermentation, whole grain intake has
remained less than one–third of the recommendation [46]. However, more research is needed to
elucidate the role of whole grains as both a standalone component and how its mode of action is
affected by other nutrients and systems in the body.
Identifying rodent models that respond to these dietary treatments may prove valuable to
research on human health. It is important to understand how these bioactive components work in
isolation, but only as a prelude to understanding how they work with or against each other. The
purpose of this study was to determine if resistant starch, whole grains, and fat can improve gut
health. The objectives were to determine if moderate dietary fat consumption provided greater
health effects than high dietary fat consumption, and if a whole grain diet with increased resistant
starch was more efficacious than a non–whole grain resistant starch diet. In order to accomplish
this, we designed a study to determine how these bioactive components acted individually and to
examine the compatibility of the components in regards to gut fermentation.

13

3.2. Materials and Methods
Animals and diets
The protocol for this study was approved by the Institutional Animal Care and Use
Committee (IACUC) at Louisiana State University. Male Sprague Dawley rats were purchased
at six weeks of age from Harlan Laboratories Inc. (Indianapolis, IL). Rats were quarantined for
one week and fed a standard chow diet. Following quarantine, animals were randomly stratified
into eight groups by body weight (average 259±8.4 grams).

All animals were housed in

individual stainless steel hanging cages with wire mesh bottom to prevent coprophagy and
determine food spilled. Rats were housed in a locked facility in a room with a 12:12 h light–dark
cycle, 21–22°C temperature, and 55% relative humidity. Rats were allowed ad libitum access to
food and water, and body weight, food intake, and food spilled were measured twice per week
for six weeks.
The experimental design for this study was a 2x2x2 factorial (Figure 3.1) with the
following factors: (1) Resistant starch (High or Low/No), (2) Whole Grain (Present or Absent),
and (3) FAT (Moderate, 30% of energy, or High, 42% of energy). For this study, 96 rats were
stratified into 8 groups (n = 12 per group). Groups consisted of moderate fat (MF) and high fat
(HF) diets prepared to contain each of the following starch sources: (1) control starch with no
WG or RS [CON], (2) whole grain waxy corn flour with low RS [WWG], (3) purified high–
amylose maize (HAM) resistant starch (RS) [HAMRS], and (4) WG HAM flour rich in resistant
starch (WG+RS) [HMWG]. The eight diet conditions were fed for six weeks.
Diet treatments were based on the AIN–93M purified diet for rodents [65].

The

compositions of the diets are listed in Table 3.1. All diets contained one major starch source as
either a purified starch product or in whole grain flour, and starches and whole grain flours were
analyzed by proximate analysis (Medallion Labs for Ingredion Incorporated). Starches consisted
14

of: (1) AMIOCA® waxy corn starch, (2) HI–MAIZE® resistant corn starch, (3) Waxy whole
grain corn flour, or (4) HI–MAIZE whole grain resistant corn flour.

Diets with RS were

calculated to contain 23% RS by weight. Diets with waxy whole grain starch were calculated to
have 4.93% RS, because the whole grain kernel has the resistant starch component in the bran as
long as it is not overly processed. RS content was determined by Ingredion Incorporated using
the modified Englyst Assay [66].

Figure 3.1 Experimental Design. Study was designed as a 2x2x2 factorial. Each of eight
groups (n=12) contains a level of each factor: Resistant Starch, Whole Grain, FAT. Levels for
factors are Resistant Starch (High or Low or No), Whole Grain (Present or Absent) and FAT
(Moderate or High).
Cellulose and AMIOCA waxy corn starch were used to moderate the energy of each diet
so that all diets within moderate fat or high fat, respectively, were isocaloric. MF and HF diets
were calculated to provide 3.75±0.01 kcal/g and 4.2± 0.07kcal/g respectively. Casein was the
major source of protein for the diets. Casein present in the diet differs from the typical 140 g/kg
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found in AIN–93M diets because the starches contain small amounts and whole grain corn flours
do contain considerable amounts of protein. Corn oil and lard were used to provide the major
source of fat in the diets. Fats were calculated to provide ~30% of energy for MF and ~42% of
energy for HF diets. Fats were chosen to represent a ratio of saturated and unsaturated fats of
1 2

1 1

: for MF and 2 : 2 for HF. Corn oil was used instead of soybean oil (AIN–93M) to better

3 3

reflect fats present in the corn kernel used to derive the corn starches and corn flours used and
was adjusted by the amount of fat present in starches and whole grain flours. A small amount of
tert–Butylhydroquinone (TBHQ) was present in the corn oil as a preservative. Vitamins and
minerals were in accordance with the AIN–93M diets, except for choline bitartrate, which was
substituted with choline chloride.
Table 3.1. Diet Composition
1

CON
Ingredients
Waxy corn starch2
High–amylose
corn starch3
High–amylose
whole grain starch
Waxy whole
grain starch4
Sucrose
Casein5
Cellulose
Corn oil6
Lard6
Mineral mix
Vitamin mix
Choline chloride
L–Cystine
Total
Resistant Starch, %7
Total Energy, kcal

Grams
473.30

Moderate Fat
HAMRS
Grams
72.31

WWG
Grams
67.83

HMWG
Grams
143.74

0.00

524.00

0.00

0.00

0.00

0.00

0.00

520.00

0.00

0.00

500.00

0.00

100.00
136.00
115.00
85.00
42.50
35.00
10.00
1.40
1.80
1000.00
0
3757

100.00
133.12
0.00
79.87
42.50
35.00
10.00
1.40
1.80
1000.00
23.37
3750

100.00
99.42
78.00
64.05
42.50
35.00
10.00
1.40
1.80
1000.00
0
3761

100.00
80.56
24.00
41.00
42.50
35.00
10.00
1.40
1.80
1000.00
23.45
3754
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Table 3.1. Diet Composition continued.
1

CON

High Fat
HAMRS
Grams
0.00

WWG
Grams
0.00

HMWG
Grams
77.85

Ingredients
Grams
2
Waxy corn starch
405.80
High–amylose
0.00
524.66
0.00
0.00
corn starch3
High–amylose
0.00
0.00
0.00
525.00
whole grain starch
Waxy whole
0.00
0.00
517.00
0.00
grain starch4
Sucrose
100.00
100.00
100.00
100.00
5
Casein
136.75
133.70
98.74
80.58
Cellulose
110.00
0.00
56.91
10.00
6
Corn oil
99.25
93.44
79.15
58.37
Lard6
100.00
100.00
100.00
100.00
Mineral mix
35.00
35.00
35.00
35.00
Vitamin mix
10.00
10.00
10.00
10.00
Choline chloride
1.40
1.40
1.40
1.40
L–Cystine
1.80
1.80
1.80
1.80
Total
1000.00
1000.00
1000.00
1000.00
23.32
4.93
23.41
0
Resistant Starch, %7
4136
4230
4209
4164
Total Energy, kcal
1
Diets include: CON = Amylopectin control corn starch containing no resistant starch diet;
HAMRS = Purified High–amylose resistant starch (HAMRS) corn starch diet; WWG = waxy
whole grain amylopectin control corn flour containing low resistant starch diet; HMWG =
whole grain HAMRS corn starch diet.
2
AMIOCA® corn starch.
3
HI–MAIZE® resistant corn starch.
4
Waxy & high–amylose corn starches and whole grain flours were gifts from Ingredion
Incorporated (Bridgewater, NJ).
5
Casein was reduced in each diet based on the protein constituent in AMICOA® and HI–
MAIZE® corn starches and whole grain flours analyzed by proximate analysis performed by
Medallion Labs for Ingredion Incorporated, and differs from the AIN–93M standard 140 g/kg.
6
Corn oil was modified in each diet based on the fat content in AMICOA® and HI–MAIZE®
corn starches and whole grain flours analyzed by proximate analysis performed by Medallion
Labs (Minneapolis, MN) for Ingredion Incorporated (Bridgewater, NJ), and differ from the
AIN–93M standard 40 g/kg. Corn oil and lard were calculated to adjust fat present in all diets to
~ 30% of energy for moderate fat, and ~42% of energy for high fat.
7
Diets with high amylose starch contain resistant starch type 2, but the whole grain flour with
high amylose has both resistant starches 1 and 2. Diets with waxy whole grain flour contain
only resistant starch type 1. Resistant starch content of experimental starches was determined
by Ingredion Incorporated using modified Englyst assay [66].
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Euthanasia
Rats were euthanized and exsanguinated by cardiac puncture after inhalation of
isoflurane anesthesia delivered by soaked cotton balls in a sealed bell jar. Several collections
were made. For each rat, a blood sample was collected in a tube with dipeptidyl peptidase IV
inhibitor for the measurement of serum active glucagon–like peptide 1 (GLP–1) levels. Active
GLP–1 was measured with an enzyme–linked immunosorbent assay (ELISA) kit (ALPCO, NH).
The gastrointestinal (GI) tract was removed from the base of the esophagus to the anus. The GI
tract was then separated into individual parts: stomach, small intestine, cecum, and large
intestine. GI tract divisions were weighed full and empty. Subcutaneous inguinal fat and
abdominal fat pads (epididymal, perirenal, and retroperitoneal) were collected and weighed to
determine percentage of abdominal fat (ABF%). Abdominal fat percent was calculated as the
abdominal fat pads divided by the body weight of the rat with the GI tract contents weight
removed (ABF =

Abdominal Fat Pads
* 100).
Body weight – Full GI + Empty GI

The denominator in the equation is

referred to as emboweled body weight (EBW). Inguinal and epididymal fat pads were frozen in
liquid nitrogen and stored at –80°C for later analysis. Cecal contents were collected and divided
into 0.5 g aliquots. Cecal contents were frozen in liquid nitrogen for measurement of pH and
short–chain fatty acids (SCFAs).
Cecal contents pH and short–chain fatty acids analysis
Cecal contents were thawed and 0.5 g of sample was vortexed with 5 ml of distilled water
for pH measurements.

Each sample was acidified with 1 ml 25% (wt/wt) solution

metaphosphoric acid containing an internal standard for SCFAs, 2 g/L 2–ethyl–butyric acid.
Samples were centrifuged at 8,000 X g for 10 minutes to separate solids and then the supernatant
liquid was filtered through a Millipore filter (MILX HA 33 mm, 0.45 μm MCE STRL; Fisher
18

SLHA 033SS). The filtered supernatant liquid was carefully transferred to a gas chromatography
(GC) autosampler vial. SCFAs were analyzed by gas–liquid chromatography for quantitative
determination. Detailed methods for quantification of SCFAs via GC have been described in a
previous publication from our lab [9].
Statistical Analysis
Statistical analysis was performed using Statistical Analysis Software SAS® version 9.4.
A 2x2x2 factorial analysis was performed followed by an F–protected least significant difference
(LSD) post–hoc means comparison test using the MIXED procedure. The three factors were
resistant starch (RS, High or Low/No), whole grain (WG, Present or Absent), and fat (FAT, High
or Moderate). Tests for normality, equal variance, and identification of outliers were conducted
using the UNIVARIATE procedure.

When normality assumption was not true, data were

transformed to log10. The following variables were transformed due to non–normal distribution
(w<0.05 for Shapiro–Wilk test): empty cecum weight (ECW); acetate, propionate, and butyrate
in ceca.
An F–statistic of <0.05 was considered statistically significant for interactions and main
effects. Within interactions and main effects, a p–value <0.05 was considered a statistically
different observation, and expressed as means ± pooled SE. If interactions were not significant,
data were collapsed from three–way interactions, to two–way interactions, to finally main
effects.

Samples more than two standard deviations away from the pooled mean were

considered as outliers and were removed only if their presence prevented normal distribution for
statistical analysis.
3.3. Results
The study findings support two of the hypotheses, but do not support the third. Moderate
fat diets were better than high fat diets for increasing markers of fermentation. High fat diets
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attenuated fermentation, and negatively impacted food and energy intake and abdominal body
fat. The whole grain resistant starch prebiotic did ameliorate the attenuation of fermentation by
high fat diets, but was not more efficacious than a purified non–whole grain resistant starch.
Whole grain combined with resistant starch was effective for maintaining, instead of reducing,
fermentation, but not more effective than the purified resistant starch for increasing fermentation.
Data were examined and outliers were removed. One outlier was removed for ABF%
(WWG HF: 4.459), Total Abdominal Fat (WWG HF: 25.359) mmol propionate produced
(HAMRS MF: 0.0127), and mmol butyrate produced (HAMRS MF: 0.014). Four outliers were
removed for cecal contents pH (CON HF: 6.57; HAMRS HF: 8.23; HMWG MF: 6.12, 7.78).
Six outliers were removed for active GLP–1 (CON HF: 2.053; HAMRS HF: 2.442; HAMRS
MF: 1.971, 3.218; HMWG HF: 1.823; HMWG MF: 2.831).
Main Effects
Descriptive data and analysis of main effect for the factors RS, WG, and Fat are shown in Table
3.2. Food and energy intake, fermentation-associated factors, and physiological variables were
examined. Data for main effects are presented as means with pooled SEM in Table 3.2.
Table 3.2. Descriptive statistics about response to dietary factors1.
Resistant Starch
Variables
Food Intake (g)
Energy intake (kcal)
Active Glucagon–like
peptide 1 (pM)
Cecal contents pH
Empty Cecum Wt. (g)
Acetate (mmol)
Propionate (mmol)
Butyrate (mmol)
Abdominal body fat %3
Total Abdominal Fat (g)
Emboweled body weight (g)

p–value (F)2

High

Low/No

Pooled SEM

746.07
2962.97

758.25
3013.30

6.9200
27.8558

0.2227
0.2117

1.3297a

0.9384b

0.0276

<0.0001

6.5346a
1.7672a
0.4688a
0.0732a
0.0870a
2.0724a
11.4133a
383.88a

8.1295b
0.4965b
0.0916b
0.0147b
0.0228b
2.5548b
14.2805b
400.20b

0.0415
0.0227
0.0131
0.0024
0.0036
0.0502
0.3198
3.4372

<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
0.0012
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Table 3.2. Descriptive statistics about response to dietary factors1 continued.
Whole Grains
Variables
Present
Absent
Pooled SEM p–value (F)2
Food Intake (g)
758.85
745.48
7.0101
0.1814
Energy intake (kcal)
3013.66
2962.60
28.2646
0.2052
Active Glucagon–like
1.0965
1.1716
0.0295
0.0775
peptide 1 (pM)
Cecal contents pH
7.4355a
7.2285b
0.0443
0.0017
Empty Cecum Wt. (g)
1.0788
1.1849
0.0260
0.8288
a
b
Acetate (mmol)
0.2596
0.3008
0.0162
0.0066
Propionate (mmol)
0.0504
0.0374
0.0031
0.4870
a
b
Butyrate (mmol)
0.0648
0.0449
0.0044
<0.0001
Abdominal body fat %3
2.3452
2.2821
0.0502
0.3796
Total Abdominal Fat (g)
13.0343
12.6596
0.3201
0.4101
Emboweled body weight (g)
394.44
389.64
3.4422
0.3262
Fat
Variables
Moderate
High
Pooled SEM p–value (F)
a
b
Food Intake (g)
777.04
727.28
7.0101
<0.0001
Energy intake (kcal)
2921.68a
3054.59b
28.2646
0.0013
Active Glucagon–like
1.1227
1.1454
0.0295
0.5896
peptide 1 (pM)
Cecal contents pH
7.3466
7.3174
0.0443
0.6438
Empty Cecum Wt. (g)
1.2100a
1.0537b
0.0261
0.0145
Acetate (mmol)
0.3040
0.2564
0.0162
0.1417
Propionate (mmol)
0.0440
0.0439
0.0031
0.9230
Butyrate (mmol)
0.0592
0.0505
0.0044
0.0145
3
a
b
Abdominal body fat %
2.2231
2.4042
0.0500
0.0126
Total Abdominal Fat (g)
12.3191a
13.3748b
0.3201
0.0220
Emboweled body weight (g)
391.00
393.08
3.4422
0.6711
1
Data are shown based on factors, resistant starch (RS, High; or Low or No), whole grains (WG,
Present or Absent) and fat (FAT, High or Moderate).
2
An F–ANOVA statistic p<0.05 indicates a significant measurement. Means with different letters
attached to numbers denote significant differences between groups (p<0.05).
3

ABF%:

Abdominal Fat Pads
Body weight – Full GI + Empty GI

* 100

Resistant Starch
While food and energy intake were not significantly different between the two RS
groups, other variables differed. as Animals fed diets high in RS vs. no or low RS demonstrated
increased serum active GLP–1, ECW, mmoles of SCFA produced, and decreased cecal contents
pH, EBW, total abdominal fat and ABF%. Empty cecum weight and mmoles SCFAs produced
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are two of several indicators of increased fermentation in the gut of rodents. These significant
effects were evident when levels of FAT and WG were collapsed into high RS and no or low RS.
However, active GLP–1, ABF%, and EBW were the only significant main effects not included in
interaction effects (Figures 3.2A–C).
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Active GLP–1 (pM)
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A
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B
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1
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Figure 3.2. Variables significantly different between RS and NRS that are present only as main
effects. Grouping includes: RS = high resistant starch, NRS = low or no resistant starch. Data
are shown collapsed to one factor, resistant starch (RS, High; or Low or No), with the other
factors whole grain (WG, Present or Absent) and fat (FAT, High or Moderate) present in both
levels of RS. Data are expressed in their original form as means ± standard error. Different
letters above each bar denote significant differences at p<0.05.
Whole Grain
Most variables did not differ between animals fed diets with and without whole grains.
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Those fed whole grains, however had increased cecal contents pH, and decreased acetate, and
increased butyrate production. These significant effects were evident when levels of RS and
FAT were collapsed into WG presence and WG absence.

These main effects are part of

interaction effects presented later.
Fat
Differences were observed between rats fed diets with high and moderate levels of fat.
Animals fed HF diets had reduced food (Figure 3.3A) and increased energy intake (Figure 3.3B).
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Figure 3.3. Variables significantly different between MF and HF present only as main effects.
Grouping includes: MF = moderate fat and HF = high fat. Data are shown collapsed to one
factor, fat (FAT, High or Moderate), with the other factors resistant starch (RS, High; or Low or
No) and whole grain (WG, Present or Absent) present in both levels of fat. Data are expressed in
their original form as means ± standard error. Different letters above each bar denote significant
differences at p<0.05.
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Those fed HF diets also had decreased ECW and increased ABF% (Figure 3.3C).

These

significant effects were evident when levels of RS and WG were collapsed into MF and HF. The
significant effect for FAT for increased ECW with MF diets is presented below in interaction
effects with RS and WG and approaching significance for RS with WG and with FAT.
Two–way Interactions
Resistant Starch * Whole Grain interaction
Several two–way interactions were noted for RS and WG fermentation variables. Interactions
were observed for cecal contents pH, ECW, and mmoles SCFA per cecum. Food and energy
intake and body composition variables did not interact. Data for two–way interactions are
presented as means with pooled SEM in Table 3.3.
Table 3.3. Two-way interactions for fermentation variables1.
RS * WG Interaction
RS
RS
NRS
NRS
Variables
WG
NWG
WG
NWG
Food Intake (g)
750.58
741.56
767.11
749.40
Energy intake (kcal)
2980.73
2945.20
3046.59
2980.00
Glucagon–like
1.2730
1.3864
0.9200
0.9568
peptide 1 (pM)
Cecal contents pH
6.8702a
6.1989b
8.0008c
8.2582d
Empty Cecum Wt. (g)
1.62474a
1.9312b
0.5302c
0.4628d
a
b
c
Acetate (mmol)
0.4060
0.5316
0.1132
0.0700d
Propionate (mmol)
0.0581a
0.0882b
0.0167c
0.0127d
a
a
b
Butyrate (mmol)
0.1002
0.0738
0.0295
0.0160c
3
Abdominal body fat %
2.1153
2.0295
2.5751
2.5346
Total Abdominal Fat (g) 11.7018
11.1248
14.3667
14.1943
Emboweled body weight
386.32
381.43
402.57
397.84
(g)
RS * FAT Interaction
RS
RS
NRS
NRS
Variables
MF
HF
MF
HF
Food Intake (g)
775.13
717.01
778.95
737.55
Energy intake (kcal)
2914.48
3011.45
2928.87
3097.73
Glucagon–like
1.3171
1.3424
0.9283
0.9484
peptide 1 (pM)
Cecal contents pH
6.5415
6.5276
8.1517
8.1073
Empty Cecum Wt. (g)
1.9161
1.6183
0.5039
0.4891
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Pooled
SEM
9.7863
39.3940

p–value
(F)2

0.0390

0.3630

0.0311
0.0067
0.0115
0.0022
0.0031
0.0709
0.4523

<0.0001
<0.0001
<0.0001
<0.0001
0.0200
0.7504
0.6561

4.8680

0.9872

Pooled
SEM
9.7863
39.3940

p–value
(F) 2

0.0390

0.9506

0.0587
0.0321

0.8086
0.1380

0.6619
0.6986

0.4017
0.3713

Table 3.3. Two-way interactions for fermentation variables1 continued.
RS * FAT Interaction
RS
RS
NRS
NRS
Pooled p–value
(F) 2
Variables
MF
HF
MF
HF
SEM
Acetate (mmol)
0.5148
0.4227
0.09315
0.09000
0.1850 0.1508
Propionate (mmol)
0.07256
0.07375
0.01536
0.01398
0.0034 0.3262
Butyrate (mmol)
0.09486
0.07908
0.02350
0.02200
0.0050 0.4660
Abdominal body fat %3
1.9929
2.1520
2.4533
2.6564
0.0709 0.7577
Total Abdominal Fat (g) 10.9128
11.9139
13.7254
14.8356
0.4523 0.9043
Emboweled body weight
382.35
385.40
399.65
400.75
4.8680 0.8426
(g)
WG * FAT Interaction
WG
WG
NWG
NWG
Pooled p–value
(F) 2
Variables
MF
HF
MF
HF
SEM
Food Intake (g)
788.57
729.12
765.51
725.44
9.9137 0.3314
Energy intake (kcal)
2965.02
3062.31
2878.33
3046.87 39.9722 0.3756
Glucagon–like
1.0965
1.0965
1.1489
1.1943
0.0417 0.5888
peptide 1 (pM)
Cecal contents pH
7.4807
7.3903
7.2125
7.2445
0.0313 0.3331
Empty Cecum Wt. (g)
1.0936
1.0641
1.3264
1.0433
0.0185 0.2388
a
a
a
b
Acetate (mmol)
0.2559
0.2633
0.3521
0.2495
0.0114 0.0154
Propionate (mmol)
0.0335a
0.0413ab
0.0544c
0.0464bc
0.0022 0.0052
Butyrate (mmol)
0.0665
0.0631
0.0518
0.0380
0.0031 0.0775
3
Abdominal body fat %
2.2416
2.4488
2.2047
2.3595
0.0709 0.7132
Total Abdominal Fat (g) 12.2103
13.8582
12.4278
12.8913
0.4527 0.1943
Emboweled body weight
388.11ab
400.78a
393.90ab
385.38b
4.8680 0.0322
(g)
1
Data are shown as full or collapsed interactions based on significant factors, resistant starch
(RS, High; or Low or No), whole grain (WG, Present or Absent), and fat (FAT, High or
Moderate).
2
An F–ANOVA statistic p<0.05 indicates a significant measurement.
Abdominal Fat Pads
3
Abdominal body fat %:
∗ 100
Body weight – Full GI + Empty GI
The two–way interaction between WG and RS for pH of cecal contents (Figure 3.4)
indicated that the presence of WG had a different effect with low or no RS present than when
there was high RS in the diet. The cecal content pH values were higher in the animals fed low
or no levels of RS and in the RSWG group compared to RSNWG diets, and a lower pH indicates
increased fermentation in the cecum. In the waxy whole grain control flour groups there was a
low amount of RS (4.93% of diet) only as RS1. These two waxy whole grain control flour
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groups (HF and MF included) have a lower pH (p<0.0001 for LSD mean comparison) than the
NWG groups that had essentially no RS. This means that the presence of RS resulted in some
degree of fermentation. With high RS in the diet, the groups with no WG (HF and MF diets
combined) had a significantly lower cecal contents pH than groups with WG present (p<0.0001
for LSD mean comparison). This indicates that the high RS diet with only RS2 may ferment
better than the combination of RS1 and RS2 in the WG high RS diets. The HAMRS groups had
23% resistant starch as RS2, but HMWG groups had an estimated 18.2% RS2, calculated by
subtracting 4.93% (RS1) from 23% (total RS) in the diets. The WG resistant starch RS1 value of
4.93% was only an estimate because of the difference in corn variety (waxy vs. HI–MAIZE
corn).
9
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Figure 3.4. Two–way interaction of RS*WG on pH of cecal contents. Grouping includes: RS2 =
high resistant starch, NRS = low resistant starch 1 or no resistant starch, WG = whole grain flour
as waxy whole grain or high amylose maize whole grain, and NWG = no whole grain. Data are
shown collapsed on two factors, resistant starch (RS, High; or Low or No) and whole grain (WG,
Present or Absent) with no significant interaction with the third factor fat (FAT, High or
Moderate). Data are expressed in their original form as means ± standard error. Different letters
above each bar denote significant differences at p<0.05.
As previously stated, increased ECW is an indicator that greater fermentation has occurred in the

26

cecum (Figure 3.5A).

Increased amounts of SCFA in cecal contents also indicate greater

fermentation. The possible explanation for the significant two–way interactions between RS and
WG for ECW (Figure 3.5A), acetate (Figure 3.5B) and propionate (Figure 3.5C) in cecal
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Figures 3.5. Two–way interactions of RS*WG on ECW and mmoles SCFAs. Grouping includes:
RS = high resistant starch, NRS = low resistant starch 1 or no resistant starch, WG = whole grain
flour as waxy whole grain or high amylose maize whole grain, and NWG = no whole grain. Data
are shown collapsed on two factors, resistant starch (RS, High; or Low or No) and whole grain
(WG, Present or Absent) with no significant interaction with the third factor fat (FAT, High or
Moderate). Data are expressed in their original form as means ± standard error. Different letters
above each bar denote significant differences at p<0.05.
The presence of RS1 in the waxy whole grain control groups (HF and MF groups) had greater
fermentation than the groups with no WG and no RS (p<0.0013 for ECW, p<0.0001 for acetate
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and propionate for LSD mean comparison). The data from the high RS groups (HF and MF
groups) with only RS2 indicated that fermentation was better with RS2 only than with the
combination of RS1 and RS2 in the whole grain (p<0.0018 for ECW, p<0.0001 for acetate and
propionate for LSD mean comparison).
A significant interaction was noted between RS and WG for butyrate in cecal contents
(Figure 3.5D). It was in the opposite direction from the relationships observed for pH of cecal
contents, ECW, and acetate and propionate in cecal contents. The presence of WG in both high
RS and low or no RS resulted in numerical or significantly increased amounts of butyrate in
cecal contents, respectively (p<0.0001 for LSD means comparison).
Resistant Starch * FAT interaction
No statistical differences were observed for the interaction between RS and FAT for any
of the parameters. No dependent variables demonstrated a p–value approaching significance for
this interaction.

Differences observed in RS and FAT on several dependent variables are

independent of the other factor.
Whole Grain * FAT interaction
Two–way interactions were noted for factor WG with factor FAT for EBW and acetate
and propionate cecal contents (Figure 3.7). Data for two–way interactions are presented as
means with pooled SEM in Table 3.3. The explanation as to why the factor WG interacts with
the factor FAT for EBW may be because the WG groups (high and low RS combined) have a
greater EBW (p<0.0283 for LSD mean comparison) with consumption of a high fat diet than
NWG, but a lower EBW (numerical) than NWG groups (high and low RS combined) with
consumption of a MF diet.
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Figure 3.7. Two–way interactions of WG*FAT on EBW and mmoles SCFAs acetate and
propionate. Grouping includes: WG = whole grain flour as waxy whole grain or high amylose
maize whole grain, NWG = no whole grain, MF = moderate fat and HF = high fat. Data are
shown collapsed on two factors, whole grain (WG, Present or Absent) and fat (FAT, High or
Moderate) with no significant interaction with the third factor resistant starch (RS, High; or Low
or No). Data are expressed in their original form as means ± standard error. Different letters
above each bar denote significant differences at p<0.05.
Acetate and propionate produced had similar responses for the WG * FAT interaction.
Production of acetate was greater (p<0.0033 LSD mean comparison) for NWG groups (high and
low or no RS combined) with consumption of a MF diet than with consumption of a HF diet; but
for WG there was no difference in production of acetate in cecal contents with either a MF or HF
diet. This resulted in a significant interaction for acetate in cecal contents. Production of acetate
was consistent for WG groups regardless of level of fat in the diet, but the high RS NWG group
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fed a MF diet produced greater amounts of acetate than when fed high RS NWG with a HF diet
(p<0.0063, LSD mean comparison). Although not significant, a similar hypothesis explains the
interaction between WG and Fat with greater production of propionate in cecal contents in rats
fed high RS in a MF diet compared to the HF diet.
Three–way Interactions
Resistant Starch * Whole Grain * FAT interaction
Empty cecum weight was only one three–way interaction that approached significance
(p=0.0526) among the three factors (Figure 3.8). The explanation of these findings suggest a
consistent fermentation of WG in both MF and HF diets with and without RS2, but high RS
NWG fermented best on a MF diet compared to a HF diet demonstrated by ECW. Data for all
three–way interactions are presented as means with pooled SEM in Table 3.4.

Empty Cecum Weight (g)

2.5
2
1.5
MF
HF

1
0.5
0
NWG

WG

NWG

WG

Low RS1 or no RS

High RS2

Figure 3.8. Three–way interaction of RS*WG*FAT on ECW. The interaction for RS*WG*FAT
(p=0.0526) is presented. Grouping includes: RS = high resistant starch type 2 or high RS2 plus
low RS1, NRS = low resistant starch 1 or no resistant starch, NWG = no whole grain, WG =
whole grain flour as high amylose maize (High RS2) whole grain or waxy whole grain (Low
RS1), MF = moderate fat and HF = high fat. Data are shown as three factors, resistant starch
(RS, High; or Low or No) and whole grain (WG, Present or Absent) with the third factor fat
(FAT, High or Moderate). Data are expressed in their original form as means ± standard error.
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Table 3.4. Three-way interactions for fermentation variables1.
RS * WG * Fat Interaction
RS
RS
NRS
NRS
WG
NWG
WG
NWG
Pooled p–value
(F)2
MF
MF
MF
MF
SEM
Variables
(HF)
(HF)
(HF)
(HF)
780.41
769.84
769.72
761.19
Food Intake (g)
13.8399 0.4147
(720.74)
(713.29)
(737.50)
(737.60)
2934.36
2894.60
2995.67
2862.07
Energy intake (kcal)
55.7115 0.4346
(3027.11) (2995.80) (3097.52) (3097.94)
Glucagon–like
1.2696
1.3646
0.9234
0.9332
0.0552 0.9189
peptide 1 (pM)
(1.2765)
(1.4083)
(0.9165)
(0.9803)
6.9480
6.1350
8.0133
8.2900
Cecal contents pH
0.0830 0.2046
(6.7925)
(6.2627)
(7.9882)
(8.2264)
1.0936
2.1981
0.5441
0.4637
Empty Cecum Wt. (g)
0.0182 0.0526
(1.6118)
(1.6248)
(0.5164)
(0.4168)
0.3984
0.6312
0.1134
0.07291
Acetate (mmol)
0.0261 0.3004
(0.4136)
(0.4319)
(0.1130)
(0.0670)
0.0501
0.0950
0.0168
0.0139
Propionate (mmol)
0.0048 0.3953
(0.0661)
(0.0814)
(0.0166)
(0.0114)
0.1032
0.0866
0.0299
0.0171
Butyrate (mmol)
0.0071 0.5485
(0.0972)
(0.0610)
(0.0291)
(0.0149)
2.0298
1.9560
2.4533
2.4533
Abdominal body fat %3
0.1002 0.8416
(2.2008)
(2.1031)
(2.6968)
(2.6159)
10.9734
10.8521
13.4472
14.0035
Total Abdominal Fat (g)
0.6396 0.7638
(12.4303) (11.3975) (15.2862) (14.3851)
Emboweled body weight
379.98
384.73
396.24
403.06
6.8844 0.8439
(g)
(392.66)
(378.14)
(408.90)
(392.61)
1
Data are shown as full or collapsed interactions based on significant factors, resistant starch
(RS, High; or Low or No), whole grain (WG, Present or Absent), and fat (FAT, High or
Moderate).
2
An F–ANOVA statistic p<0.05 indicates a significant measurement.
Abdominal Fat Pads
3
Abdominal body fat %:
∗ 100
Body weight – Full GI + Empty GI
3.4. Discussion
Results from the current study demonstrated that three factors (RS, WG, FAT) produce
individual main effects and interaction effects with each other. Strong independent effects on
fermentation and phenotype were observed as well as interactions between factors that shape the
parameters of fermentation. There was an observed effect on ECW that approached significance
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in a three–way interaction among the RS, WG and FAT factors. RS and FAT appear to be the
primary factors driving differences observed for many of the dependent variables analyzed
because of main effects for variables not included in interactive effects. Two–way interactions
between WG and FAT and RS and WG were observed but not between RS and FAT.
Several of our previous studies demonstrated that consumption of RS was associated with
a reduction in normalized abdominal body fat hypothesized to be the result of increased
fermentation [3, 4, 9]. Similar results occurred in the present study with main effects of RS for
increased ECW and active GLP–1, and decreased ABF% and EBW. In the current study, RS
and WG interactions were demonstrated for cecal contents pH, ECW and cecal contents acetate,
propionate and butyrate. These suggested that the WG control fermented better than the non–
WG control because of the presence of a small but significant amount of RS1. However, the
presence of WG resulted in greater amounts of butyrate, but lower amounts of acetate and
propionate. Within these interactions there was consistent production of acetate and propionate
with consumption of WG with a MF or a HF diet, but reduced amounts produced with the
consumption of purified high RS product with a HF diet. This means that the purified high RS
product was negatively affected by the HF diet. Although the interaction was statistically
significant, the high RS WG groups and the high RS non–WG groups only had numerically
higher values for butyrate. Increased amounts of butyrate with WG diets may be beneficial as
butyrate is a major energy source for the colonocytes [25] and butyrate is considered beneficial
to the health of the gut [67]. Along with lactate produced by the microbiota, acetate can be
utilized by bacteria, in genera such as Clostridium cluster IV and Clostridium cluster XIV to
produce butyrate [30, 31]. This may be a reason why acetate was significantly reduced in the
WG groups.
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The SCFAs measured have other distinct properties. Acetate and propionate produced in
the colon can be found in the small and large intestines, portal, hepatic and peripheral blood [25].
These SCFAs are utilized by peripheral tissues (muscle, acetate) or by the liver (acetate,
propionate) for metabolism [26–29]. Acetate and butyrate may have a role in modulating
glucose metabolism [68]. Propionate has an important role as a precursor to metabolites in
gluconeogenesis [69], and influences regulation of blood pressure through Olfactory receptor 78
and G protein coupled receptor 41 [70].
We hypothesized that a moderate fat diet would provide a similar phenotype (body
weight, ABF%, food and energy intake, etc.) to low fat diets, and would lie between low and
high fat diets in fermentation parameters (cecal contents pH, SCFAs, ECW, etc.). If these
hypotheses were valid then we would be able to show that moderate dietary fat consumption
provides greater health benefits than high dietary fat consumption. Our lab group has shown that
moderate fat diets were comparable to low fat diets on ABF% in C57Bl/6J mice [10]. In our
previous studies, diets low in fat contributed to a healthier gut (Zhou et al., 2009), while a high
fat diet attenuated fermentation and phenotype effects (Charrier et al., 2013). In the current study
the MF diet was associated with a lower ABF% and a greater ECW.
FAT and WG had significant interactions on EBW and acetate and propionate in cecal contents.
The interactions were the result of opposite effects of HF and MF diets depending on the
presence or absence of WG.
We also hypothesized that a whole grain resistant starch prebiotic would ameliorate the
negative effects caused by high fat diets. Whole grains have been shown to have many positive
effects on gut and whole body health [13, 14, 36–42]. In this study, we observed that WG had a
complicated role. For instance, WG improved fermentation variables (ECW and SCFA) for HF
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diets when compared to diets without WG. However, the presence of WG in high RS groups
reduced fermentation as indicated by increased cecal contents pH, and reduced ECW, and SCFA
produced except for butyrate. These results suggest that RS2 is better fermented than RS1
because the high RS groups without WG had 100% RS2, but the high RS groups with WG had a
combination of RS1 and RS2. The amount of RS2 in high RS groups with WG was ~5 g less
than in high RS groups without WG.
There are two possible explanations as to why RS2 appears to be more fermentable than
RS1. First, the physical arrangement of the starches differs between resistant starch forms. In
RS2, the starch forms granules to resist digestion in the small intestine. The starch in RS1 is a
component of the food matrix which acts as a barrier to amylolysis [16]. Bacteria feeding upon
these starches can rapidly ferment the RS2, whereas the starch in RS1 requires more time to
access [71]. Secondly, the site of measurement is important for determining the fermentability of
RS. Starch without the bran (e.g. purified RS2) is rapidly fermented in the cecum and proximal
colon. Govers et al. (1999) determined that starch with the bran, such as a whole grain starch, is
fermented slowly and exhibits greater fermentation in the distal colon [71]. The current study
measured the effects of RS2 in the cecum and resulted in a substantial degree of fermentation
using RS2 over RS1. This distinction is useful to examine the differences between resistant
starch and whole grain. Regional differences in fermentation mean differing implications for
risk of bowel diseases and SCFA distribution.

Regional fermentation may substantially

contribute to the finding that whole grains can reduce risk of colorectal cancers [38].
This RS2 vs. RS1 finding is in stark contrast to a previous study conducted by our lab
[72]. In that study, obese Zucker Diabetic Fatty (ZDF) rats fermented the WG prebiotic better
with and without RS compared to groups without WG in low fat diets. Although no changes in
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body fat were observed, ZDF rats demonstrated substantial fermentation and microbiota changes.
Before conducting the study, the ZDF rats were thought to be dysbiotic and poor fermenters of
RS, whereas Sprague Dawley (SD) rats had previously been shown to ferment RS robustly.
Sprague Dawley rats can be separated as obese–prone (OP) and obese–resistant (OR) based on
consumption of high fat diets, i.e. by phenotype. The genotype behind this phenotypic difference
has not been delineated (personal communication with the local representative of Charles River
animal supplier company) and is likely multigenic and more complex that many other rodent
obesity models like the obese ZDF rat. Obesity in ZDF rats is a monogenic trait, where the
leptin receptor is defective. In the current study, we did not separate by phenotype. Our
previous studies appeared to not be affected by possible different phenotypes. Also, the dominant
phenotype in the current study may not ferment RS in a WG product as well as the obese ZDF
rats [72]. For greater consistency in results, especially regarding WG, future studies should take
advantage of the Charles River colonies of cesarean–derived (CD) rats from the SD line of rat
that have been separated into two separate colonies based on the OP and OR phenotypes.
The results from the current study support our previous studies and continue to
demonstrate the benefits of consuming RS. In addition, benefits of MF diets and WG products
were also demonstrated. Moderate fat diets appear to be as effective as LF diets in promoting
fermentation of RS and other effects including normalization of abdominal body fat. Whole grain
products with and without RS demonstrated consistent fermentation in both HF and MF diets and
appear to promote increased butyrate production in the gut. However, the phenotype of rodent
(OP, OR) may affect the response to RS and WG products. This suggests that the SD rat is
likely a good model for investigating prebiotic substances, but the two phenotypes should be
separated for more consistent results.
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CHAPTER 4: CONCLUSION
This investigation demonstrated the importance of studying food components and their
interactions, rather than examining specific outcomes from single factors. In this study, there
were fermentation differences between rodents fed high RS in MF diets similar to previous
studies, mirroring significant differences between rodents fed LF and HF diets. The differences
occurred in diets without whole grain. With whole grain diets the fermentation was similar for
MF and HF diets. Also, the high RS whole grain groups had similar fermentation effects as the
group fed high RS with no whole grain as part of a HF diet. Since this level of fermentation is
still significantly greater than groups with no or low RS, these results suggest that Americans
may be able to consume the higher levels dietary fat (42% of energy) that some Americans
consume and still benefit from consumption of RS. High fat diets may attenuate fermentation,
but the addition of other bioactive components, provided by a high resistant starch whole grain
product, were hypothesized to help maintain the fermentation process. Although gut health was
improved with high RS whole grain diets as demonstrated by increased fermentation compared
to low or no RS, high RS whole grain diets did not ferment as well as purified RS2 with the
feeding of MF. This suggests that the combination of RS1 and RS2 present in the whole grain
kernel compared to an equivalent amount of RS as non–whole grain purified RS2 is not as
effective as the purified RS2. However, the WG products appear to increase butyrate production
and may benefit the health of the colonocytes.

Increased butyrate may indicate a greater

utilization of acetate for butyrate production. The results from this study and our previous
investigations also may indicate that there may be variation in response to dietary RS in a whole
grain product in people as there have been in rodents. Future obesity studies will require
multigenic models. One approach is to separate multigenic genotypes by phenotypes of obese–
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proneness and obese–resistance into subgroups using caesarean–derived SD rats. This will
address the variability found in people as opposed to studying monogenic models such as the
obese ZDF rats that have a defective leptin receptor to induce obesity.
Future studies are also needed to determine lower dietary doses of resistant starch and
whole grain high RS products that will most benefit the host. Dose response studies with RS can
be performed with purified RS or whole grain high RS products. These studies should be
performed separately with MF and HF diets to demonstrate benefits at recommended levels of
dietary fat for Americans, and the upper range of consumption of dietary fat by Americans. This
will enable increased health benefits from fiber and over a range of fat intakes, while not
extensively modifying the dietary intake of Americans. As the path to combat obesity has many
inroads, health behavior changes that do not require people to exhaustively alter or restrict their
dietary intake will be necessary to ensure that compliance and moderation remain feasible in the
face of ever evolving messaging and recommendations.
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